Healthcare provider profile · identity verified

Joyce C. Ward, MD

Family Practice · INDIAN LAND, SC · NPI 1356332779

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	565	163
Amlodipine Besylate	Amlodipine Besylate	438	140
Levothyroxine Sodium	Levothyroxine Sodium	429	127
Losartan Potassium	Losartan Potassium	399	123
Omeprazole	Omeprazole	375	106
Lisinopril	Lisinopril	301	87
Hydrochlorothiazide	Hydrochlorothiazide	293	88
Rosuvastatin Calcium	Rosuvastatin Calcium	286	80
Sertraline Hcl	Sertraline Hcl	233	71
Trazodone Hcl	Trazodone Hcl	224	76
Fluticasone Propionate	Fluticasone Propionate	212	93
Simvastatin	Simvastatin	197	60
Gabapentin	Gabapentin	168	63
Metoprolol Succinate	Metoprolol Succinate	159	50
Tizanidine Hcl	Tizanidine Hcl	156	59
Pravastatin Sodium	Pravastatin Sodium	154	42
Pantoprazole Sodium	Pantoprazole Sodium	142	45
Mounjaro	Tirzepatide	128	18
Famotidine	Famotidine	115	37
Alprazolam	Alprazolam	112	35
Escitalopram Oxalate	Escitalopram Oxalate	109	40
Enalapril Maleate	Enalapril Maleate	103	29
Lorazepam	Lorazepam	101	26
Metformin Hcl	Metformin Hcl	97	35
Montelukast Sodium	Montelukast Sodium	85	23
Citalopram Hbr	Citalopram Hydrobromide	79	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	23
Tramadol Hcl	Tramadol Hcl	72	21
Duloxetine Hcl	Duloxetine Hcl	71	25
Albuterol Sulfate Hfa	Albuterol Sulfate	69	26
Bupropion Xl	Bupropion Hcl	68	24
Fluoxetine Hcl	Fluoxetine Hcl	68	23
Meloxicam	Meloxicam	64	21
Methylprednisolone	Methylprednisolone	64	59
Metoprolol Tartrate	Metoprolol Tartrate	64	18
Buspirone Hcl	Buspirone Hcl	63	20
Zolpidem Tartrate	Zolpidem Tartrate	61	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	18
Carvedilol	Carvedilol	59	23
Atenolol	Atenolol	57	21
Ezetimibe	Ezetimibe	57	18
Furosemide	Furosemide	52	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	51	13
Glipizide Er	Glipizide	51	14
Eliquis	Apixaban	49	11
Metformin Hcl Er	Metformin Hcl	49	18
Clopidogrel	Clopidogrel Bisulfate	47	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	43	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	43	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	22
Ondansetron Hcl	Ondansetron Hcl	41	22
Synthroid	Levothyroxine Sodium	41	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	37
Allopurinol	Allopurinol	39	11
Nystatin	Nystatin	39	16
Valacyclovir	Valacyclovir Hcl	39	22
Potassium Chloride	Potassium Chloride	36	12
Diclofenac Sodium	Diclofenac Sodium	34	16
Alendronate Sodium	Alendronate Sodium	33	suppressed
Ozempic	Semaglutide	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	11
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	31
Lovastatin	Lovastatin	31	suppressed
Mirtazapine	Mirtazapine	31	13
Azithromycin	Azithromycin	30	28
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	11
Cephalexin	Cephalexin	28	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Amoxicillin	Amoxicillin	25	24
Prednisone	Prednisone	25	19
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Clonazepam	Clonazepam	24	11
Donepezil Hcl	Donepezil Hcl	23	11
Fluconazole	Fluconazole	23	22
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Glipizide	Glipizide	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Valsartan	Valsartan	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error